Nuvation Bio Inc.

NYSE:NUVB

2.3 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -75.802-104.199-86.848-41.659-33.552-0.992
Depreciation & Amortization 0.2220.1990.1840.1030.0130
Deferred Income Tax -21.10400.442000
Stock Based Compensation 19.51316.2929.2682.20200
Change In Working Capital 0.54-3.4474.7932.11-0.460.265
Accounts Receivables -1.2170.554-1.947-0.26400
Inventory 0-0.5541.9470.26400
Accounts Payables 0.07-1.7861.8610.03400
Other Working Capital 1.687-1.6612.9322.076-0.460.265
Other Non Cash Items 8.632-4.9533.9710.7159.5670.111
Operating Cash Flow -67.999-96.108-68.19-36.529-24.432-0.616
Investing Activities:
Investments In Property Plant And Equipment -0.069-0.37-0.282-0.145-0.6590
Acquisitions Net 0.0140.013454.669-2.50800
Purchases Of Investments -703.373-520.307-609.3-143.28900
Sales Maturities Of Investments 712.349584.121154.91373.11400
Other Investing Activites 0.0090.064-454.6692.508-115.1960
Investing Cash Flow 8.92163.457-454.669-70.32-115.8550
Financing Activities:
Debt Repayment 0000-14.990
Common Stock Issued 0.6281.327625.527135.65700
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.6280.001624.769-2.522128.6280.8
Financing Cash Flow 0.6281.327625.527133.135143.6180.8
Other Information:
Effect Of Forex Changes On Cash 67.99900000
Net Change In Cash -58.45-31.324102.66826.2863.3310.184
Cash At End Of Period 42.649101.099132.42329.7553.4690.184